Real-World Outcomes of Faricimab Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
Clinical Ophthalmology · 2024-05 · Volume 18 · 1479-1490
DOI: 10.2147/opth.s463624 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Ophthalmology, 2024-05. Verfasst von Nicole Q X Quah und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK.
ORCID-Profile: Nicole Q X Quah
Zitieren
APA
Quah, N. Q. X., Javed, K. M. A. A., Arbi, L., & Hanumunthadu, D. (2024). Real-World Outcomes of Faricimab Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema. Clinical Ophthalmology, Volume 18, 1479-1490. https://doi.org/10.2147/opth.s463624
Vancouver
Quah NQX, Javed KMAA, Arbi L, Hanumunthadu D. Real-World Outcomes of Faricimab Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema. Clinical Ophthalmology. 2024;Volume 18:1479-1490. doi:10.2147/opth.s463624
BibTeX
@article{Quah2024,
author = {Quah, Nicole Q X and Javed, Khawaja Muhammad Ammar Ali and Arbi, Lamees and Hanumunthadu, Daren},
title = {Real-World Outcomes of Faricimab Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema},
journal = {Clinical Ophthalmology},
year = {2024},
volume = {Volume 18},
pages = {1479--1490},
doi = {10.2147/opth.s463624}
}
EUVIMED